MARKET

BBC

BBC

Virtus LifeSci Biotech Clinical Trls ETF
NYSEARCA

Real-time Quotes | Provided by Morningstar

51.26
-2.32
-4.33%
Closed 16:00 03/04 EST
OPEN
52.45
PREV CLOSE
53.58
HIGH
52.45
LOW
50.37
VOLUME
9.20K
TURNOVER
--
52 WEEK HIGH
62.60
52 WEEK LOW
23.00
TOTAL ASSET
51.68M
YTD YIELD
0.44%
1D
5D
1M
3M
1Y
5Y
Best Biotech ETFs for Q2 2021
Investopedia · 02/03 18:47
Saudi Wealth Fund Making Another Splash, This Time at Home
Bloomberg · 11/17/2020 14:58
Traders Shorting VIX Spur Inflows to $1.2 Billion Fund Down 34%
Bloomberg · 11/17/2020 13:04
Saudi Wealth Fund Cuts U.S. Stock Holdings, Holds On to Uber
Bloomberg · 11/17/2020 05:21
Tesla Is So Huge It May Take Two Steps to Put It in the S&P 500
Bloomberg · 11/17/2020 00:09
Hedge Funds Bet on Tech Ahead of Unpredictable Fourth Quarter
Bloomberg · 11/16/2020 23:08
A $1.3 Billion Leveraged Bet Against Tech Sees Record Outflows
Bloomberg · 11/16/2020 16:52
Cathie Wood’s Ark Invest Rocked as Shareholder Seeks Control
A fight for control has broken out at one of the biggest success stories in the exchange-traded fund world this year.
Bloomberg · 11/16/2020 15:48
More
No Data
Learn about the latest financial forecast of BBC. Analyze the recent business situations of Virtus LifeSci Biotech Clinical Trls ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
08/31/2020
3 Year
Morningstar
08/31/2020
5 Year
Morningstar
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Day
-4.3198%
--
1-Week
-2.8867%
--
1-Month
-6.1209%
--
3-Month
-7.1870%
--
6-Month
7.6456%
--
YTD
0.4368%
--
1-Year
47.4713%
--
5-Year
4.6049%
--
Since Inception
7.9926%
--
No Data
No Data
  • All
No Data
Profile
Fund Name
Virtus LifeSci Biotech Clinical Trls ETF
Risk
Low risk
Inception Date
2014-12-16
Benchmark
NASDAQ Composite CR
Advisor Company
Virtus
Custodian
The Bank of New York Mellon
Manager
Brown/Kadushin